Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.
May 2025 in “Gynecological Endocrinology” This study investigated the impact of a family history of PCOS on male reproductive health by analyzing spermiogram parameters in 51 men, 25 with a first-degree relative with PCOS and 26 controls. Results showed that men with a family history of PCOS had significantly lower median sperm concentration and a higher incidence of hair loss (64%) and gynecomastia (25%). Interestingly, dyslipidemia was associated with significantly higher semen concentration and sperm motility. The findings suggest that men with a family history of PCOS exhibit distinct reproductive and metabolic characteristics.
Cyclosporine is more effective than betamethasone for treating alopecia areata, despite mild side effects.
May 2025 in “CPT Pharmacometrics & Systems Pharmacology” A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.
April 2025 in “Journal of Pioneering Medical Science” Topical minoxidil is safer and improves hair density better than oral minoxidil.
April 2025 in “Skin Health and Disease” Oral minoxidil is an effective alternative for hair loss but may cause more unwanted hair growth.
March 2025 in “Forum Dermatologicum” Metabolic syndrome may worsen certain skin conditions, and managing both together is important.
February 2025 in “PubMed” Alopecia areata cases have increased globally, affecting mostly women aged 30-34, with links to other health issues.
February 2025 in “PLoS ONE” Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.
February 2025 in “BMC Public Health” Unhealthy diet and lifestyle choices may increase the risk of hair loss in women.
January 2025 in “JAAD International” Bicalutamide added no extra benefit over minoxidil alone for female-pattern hair loss.
January 2025 in “Heliyon” Tamsulosin and finasteride have similar effects on blood sugar control in men with type 2 diabetes.
January 2025 in “International Journal of Dermatology” Consider TFI in facial hypopigmentation diagnoses and confirm with a biopsy.
January 2025 in “Journal of Drugs in Dermatology” Oral minoxidil is easier to use and more satisfying for hair loss treatment than topical minoxidil.
Topical minoxidil often causes side effects like scalp irritation, but most users continue treatment.
Topical GT20029 effectively promotes hair regrowth and is well-tolerated.
January 2025 in “Annals of Dermatology” Low-dose dutasteride effectively and safely promotes hair growth in men.
January 2025 in “International Journal of Advanced Biochemistry Research” Alpha linolenic acid and linoleic acid help treat inflammatory skin conditions in dogs.
January 2025 in “SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital” PRP injections are safe and effective for alopecia areata, but steroids are still the preferred treatment.
January 2025 in “Dermatologic Therapy” Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.
December 2024 in “Здобутки клінічної і експериментальної медицини” Advancements in skin regeneration focus on stem cells, nanotechnology, and bioengineered skin to improve healing and reduce scarring.
December 2024 in “Journal of Investigative Dermatology” The conference highlighted new treatments and research in pediatric skin conditions, emphasizing collaboration and innovation.
October 2024 in “International Journal of Dermatology” Oral and topical minoxidil are equally effective for hair loss, but oral minoxidil causes more unwanted hair growth.
October 2024 in “Clinical and Experimental Dermatology” The combination treatment didn't work better than minoxidil alone and caused more menstrual issues.
September 2024 in “JAAD International” Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.
September 2024 in “Actas Dermo-Sifiliográficas” Sublingual minoxidil is a safe and effective treatment for hair loss, especially in women.
September 2024 in “The Professional Medical Journal” Infectious skin diseases like scabies and fungal infections are common but treatable in Lahore, especially in summer.
September 2024 in “Journal of the American Academy of Dermatology” Oral minoxidil is easier to use and more satisfying for hair loss treatment but may cause more unwanted hair growth.
September 2024 in “Journal of the American Academy of Dermatology” Alopecia areata patients have a higher risk of blood clots.
July 2024 in “Dermatology Practical & Conceptual” COVID-19-related hair loss may have unique features compared to hair loss from other causes.